CA2319317C - Prognostic allergy or inflammation test - Google Patents
Prognostic allergy or inflammation test Download PDFInfo
- Publication number
- CA2319317C CA2319317C CA002319317A CA2319317A CA2319317C CA 2319317 C CA2319317 C CA 2319317C CA 002319317 A CA002319317 A CA 002319317A CA 2319317 A CA2319317 A CA 2319317A CA 2319317 C CA2319317 C CA 2319317C
- Authority
- CA
- Canada
- Prior art keywords
- allergen
- ige
- linear
- allergy
- antibodies
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010020751 Hypersensitivity Diseases 0.000 title claims abstract description 43
- 230000007815 allergy Effects 0.000 title claims abstract description 39
- 208000026935 allergic disease Diseases 0.000 title claims abstract description 37
- 238000012360 testing method Methods 0.000 title description 14
- 206010061218 Inflammation Diseases 0.000 title description 3
- 230000004054 inflammatory process Effects 0.000 title description 3
- 208000010668 atopic eczema Diseases 0.000 claims abstract description 47
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 44
- 230000000172 allergic effect Effects 0.000 claims abstract description 36
- 238000000034 method Methods 0.000 claims abstract description 35
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 34
- 150000001413 amino acids Chemical class 0.000 claims abstract description 19
- 238000012216 screening Methods 0.000 claims abstract description 17
- 239000012634 fragment Substances 0.000 claims abstract description 11
- 239000013566 allergen Substances 0.000 claims description 59
- 235000013601 eggs Nutrition 0.000 claims description 35
- 230000009257 reactivity Effects 0.000 claims description 22
- 235000013305 food Nutrition 0.000 claims description 18
- 235000017060 Arachis glabrata Nutrition 0.000 claims description 12
- 235000010777 Arachis hypogaea Nutrition 0.000 claims description 12
- 235000018262 Arachis monticola Nutrition 0.000 claims description 12
- 235000021245 dietary protein Nutrition 0.000 claims description 12
- 235000020232 peanut Nutrition 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 11
- 239000003153 chemical reaction reagent Substances 0.000 claims description 7
- 108010000912 Egg Proteins Proteins 0.000 claims description 6
- 102000002322 Egg Proteins Human genes 0.000 claims description 6
- 241000238631 Hexapoda Species 0.000 claims description 5
- 235000013336 milk Nutrition 0.000 claims description 5
- 239000008267 milk Substances 0.000 claims description 5
- 210000004080 milk Anatomy 0.000 claims description 5
- 241001465754 Metazoa Species 0.000 claims description 4
- 238000001514 detection method Methods 0.000 claims description 4
- 239000000428 dust Substances 0.000 claims description 4
- 235000014571 nuts Nutrition 0.000 claims description 4
- 230000002596 correlated effect Effects 0.000 claims description 2
- 230000000875 corresponding effect Effects 0.000 claims description 2
- 241001553178 Arachis glabrata Species 0.000 claims 6
- 108010011756 Milk Proteins Proteins 0.000 claims 6
- 241000251468 Actinopterygii Species 0.000 claims 3
- 108010028690 Fish Proteins Proteins 0.000 claims 3
- 102000014171 Milk Proteins Human genes 0.000 claims 3
- 108010003571 Nut Proteins Proteins 0.000 claims 3
- 108010064851 Plant Proteins Proteins 0.000 claims 3
- 108010054866 Shellfish Proteins Proteins 0.000 claims 3
- 235000021120 animal protein Nutrition 0.000 claims 3
- 235000019688 fish Nutrition 0.000 claims 3
- 235000021239 milk protein Nutrition 0.000 claims 3
- 235000021118 plant-derived protein Nutrition 0.000 claims 3
- 230000014759 maintenance of location Effects 0.000 claims 1
- 206010016946 Food allergy Diseases 0.000 abstract description 19
- 239000000427 antigen Substances 0.000 abstract description 18
- 102000036639 antigens Human genes 0.000 abstract description 18
- 108091007433 antigens Proteins 0.000 abstract description 18
- 102000004169 proteins and genes Human genes 0.000 abstract description 13
- 108090000623 proteins and genes Proteins 0.000 abstract description 13
- 208000004262 Food Hypersensitivity Diseases 0.000 abstract description 8
- 235000020932 food allergy Nutrition 0.000 abstract description 6
- 230000002797 proteolythic effect Effects 0.000 abstract description 6
- 238000004393 prognosis Methods 0.000 abstract description 5
- 238000011156 evaluation Methods 0.000 abstract description 4
- 208000027866 inflammatory disease Diseases 0.000 abstract description 4
- 108060003951 Immunoglobulin Proteins 0.000 abstract description 3
- 102000018358 immunoglobulin Human genes 0.000 abstract description 3
- 229940072221 immunoglobulins Drugs 0.000 abstract description 2
- 238000010561 standard procedure Methods 0.000 abstract description 2
- 108010064983 Ovomucin Proteins 0.000 description 60
- 230000027455 binding Effects 0.000 description 44
- 230000001186 cumulative effect Effects 0.000 description 15
- 239000012528 membrane Substances 0.000 description 14
- 239000000523 sample Substances 0.000 description 13
- 235000018102 proteins Nutrition 0.000 description 12
- 208000004739 Egg Hypersensitivity Diseases 0.000 description 11
- 201000010860 egg allergy Diseases 0.000 description 9
- 230000002009 allergenic effect Effects 0.000 description 8
- 210000001035 gastrointestinal tract Anatomy 0.000 description 8
- 206010012438 Dermatitis atopic Diseases 0.000 description 7
- 201000008937 atopic dermatitis Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 210000002966 serum Anatomy 0.000 description 7
- 244000105624 Arachis hypogaea Species 0.000 description 6
- 238000011161 development Methods 0.000 description 6
- 208000035475 disorder Diseases 0.000 description 5
- 239000002953 phosphate buffered saline Substances 0.000 description 5
- 108010010803 Gelatin Proteins 0.000 description 4
- 239000013568 food allergen Substances 0.000 description 4
- 239000008273 gelatin Substances 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 235000011852 gelatine desserts Nutrition 0.000 description 4
- 229920000136 polysorbate Polymers 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010003645 Atopy Diseases 0.000 description 3
- 208000015943 Coeliac disease Diseases 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 208000008267 Peanut Hypersensitivity Diseases 0.000 description 3
- 125000000539 amino acid group Chemical group 0.000 description 3
- 230000030741 antigen processing and presentation Effects 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 210000003719 b-lymphocyte Anatomy 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 238000003119 immunoblot Methods 0.000 description 3
- 230000002757 inflammatory effect Effects 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- HKJKONMZMPUGHJ-UHFFFAOYSA-N 4-amino-5-hydroxy-3-[(4-nitrophenyl)diazenyl]-6-phenyldiazenylnaphthalene-2,7-disulfonic acid Chemical compound OS(=O)(=O)C1=CC2=CC(S(O)(=O)=O)=C(N=NC=3C=CC=CC=3)C(O)=C2C(N)=C1N=NC1=CC=C([N+]([O-])=O)C=C1 HKJKONMZMPUGHJ-UHFFFAOYSA-N 0.000 description 2
- 206010009900 Colitis ulcerative Diseases 0.000 description 2
- 208000011231 Crohn disease Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 201000006704 Ulcerative Colitis Diseases 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000013595 glycosylation Effects 0.000 description 2
- 238000006206 glycosylation reaction Methods 0.000 description 2
- 210000004837 gut-associated lymphoid tissue Anatomy 0.000 description 2
- 230000009610 hypersensitivity Effects 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 230000001024 immunotherapeutic effect Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000001785 maturational effect Effects 0.000 description 2
- 239000013610 patient sample Substances 0.000 description 2
- 201000010853 peanut allergy Diseases 0.000 description 2
- 230000002085 persistent effect Effects 0.000 description 2
- 229940068196 placebo Drugs 0.000 description 2
- 239000000902 placebo Substances 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 230000000750 progressive effect Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- NSMXQKNUPPXBRG-SECBINFHSA-N (R)-lisofylline Chemical group O=C1N(CCCC[C@H](O)C)C(=O)N(C)C2=C1N(C)C=N2 NSMXQKNUPPXBRG-SECBINFHSA-N 0.000 description 1
- 241000238876 Acari Species 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241001203952 Feia Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 208000020226 Heiner syndrome Diseases 0.000 description 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
- 208000009793 Milk Hypersensitivity Diseases 0.000 description 1
- 201000010859 Milk allergy Diseases 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 208000002366 Nut Hypersensitivity Diseases 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 241000746983 Phleum pratense Species 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000013567 aeroallergen Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 108091005588 alkylated proteins Proteins 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 125000000837 carbohydrate group Chemical group 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 238000000326 densiometry Methods 0.000 description 1
- 238000000586 desensitisation Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000020805 dietary restrictions Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 210000004124 hock Anatomy 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000001629 sign test Methods 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 241000701447 unidentified baculovirus Species 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in epitope analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/02—Nutritional disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/24—Immunology or allergic disorders
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physiology (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7317198P | 1998-01-30 | 1998-01-30 | |
| US60/073,171 | 1998-01-30 | ||
| PCT/US1999/001832 WO1999039211A1 (en) | 1998-01-30 | 1999-01-28 | Prognostic allergy or inflammation test |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2319317A1 CA2319317A1 (en) | 1999-08-05 |
| CA2319317C true CA2319317C (en) | 2006-04-18 |
Family
ID=22112157
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002319317A Expired - Fee Related CA2319317C (en) | 1998-01-30 | 1999-01-28 | Prognostic allergy or inflammation test |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6238925B1 (enExample) |
| EP (2) | EP1051626B1 (enExample) |
| JP (1) | JP4292262B2 (enExample) |
| AT (2) | ATE426170T1 (enExample) |
| AU (1) | AU741635B2 (enExample) |
| CA (1) | CA2319317C (enExample) |
| DE (1) | DE69919327D1 (enExample) |
| ES (2) | ES2229673T3 (enExample) |
| WO (1) | WO1999039211A1 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10110838C2 (de) * | 2001-03-06 | 2003-04-03 | Mlu Halle Wittenberg | Verfahren zur Diagnostik von Allergien, Pseudoallergien und Intoleranzen |
| AU2002302410A1 (en) * | 2001-03-10 | 2002-09-24 | Affina Immuntechnik Gmbh | Method for identifying immune reactive epitopes on proteins |
| RU2214599C2 (ru) * | 2001-11-21 | 2003-10-20 | Самарский медицинский институт "РЕАВИЗ" | Способ выявления лиц, относящихся к группе риска по развитию аллергических заболеваний |
| MXPA05011409A (es) | 2003-04-23 | 2005-12-12 | Medarex Inc | Composiciones y metodos para la terapia de enfermedad inflamatoria intestinal. |
| PT1781705E (pt) | 2004-06-21 | 2014-12-23 | Medarex Llc | Anticorpos contra recetor i do interferão alfa e as suas utilizações |
| US8859210B2 (en) * | 2008-10-17 | 2014-10-14 | Mead Johnson Nutrition Company | Method for identifying allergenic proteins and peptides |
| JP5660027B2 (ja) * | 2009-03-05 | 2015-01-28 | 味の素株式会社 | クローン病診断試薬 |
| EP2478373B1 (en) * | 2009-09-14 | 2019-01-09 | Icahn School of Medicine at Mount Sinai | Methods for characterizing antibody binding affinity and epitope diversity in food allergy |
| WO2012135313A1 (en) * | 2011-03-28 | 2012-10-04 | University Of Massachusetts | Compositions and methods for detecting allergy to a-gal epitopes |
| EP2841098A4 (en) | 2012-04-23 | 2016-03-02 | Allertein Therapeutics Llc | NANOPARTICLES FOR THE TREATMENT OF ALLERGIES |
| JP2016516754A (ja) | 2013-04-03 | 2016-06-09 | アラーテイン・セラピューティクス・リミテッド・ライアビリティ・カンパニーＡｌｌｅｒｔｅｉｎ Ｔｈｅｒａｐｅｕｔｉｃｓ， ＬＬＣ | 新規のナノ粒子組成物 |
| KR102202575B1 (ko) | 2013-12-31 | 2021-01-13 | 삼성전자주식회사 | 메모리 관리 방법 및 장치 |
| US11215615B2 (en) | 2014-04-03 | 2022-01-04 | AllerGenis LLC | Peptides, reagents and methods for detecting food allergy |
| WO2016077808A1 (en) | 2014-11-14 | 2016-05-19 | Biomerica, Inc. | Compositions, devices, and methods of ibs sensitivity testing |
| EP3173789A1 (en) * | 2015-11-24 | 2017-05-31 | Helmholtz-Zentrum für Infektionsforschung GmbH | Method for differentiation of immune response in an individual |
| CA3062890A1 (en) * | 2016-04-26 | 2017-11-02 | Biomerica, Inc. | Compositions, devices, and methods of ulcerative colitis sensitivity testing |
| JP7062291B2 (ja) * | 2016-05-13 | 2022-05-16 | 応用酵素医学研究所株式会社 | アレルギー発症リスクを予測するためのデータを収集する方法 |
| RU2621312C1 (ru) * | 2016-06-15 | 2017-06-01 | Федеральное государственное автономное учреждение "Научный центр здоровья детей" Министерства здравоохранения Российской Федерации (ФГАУ "НЦЗД" Минздрава России) | Способ прогнозирования формирования толерантности при аллергии к белку коровьего молока у детей раннего возраста |
| KR102327467B1 (ko) * | 2016-06-16 | 2021-11-16 | 호유 가부시키가이샤 | 생선 알레르기의 항원 |
| CN109804247A (zh) | 2016-07-08 | 2019-05-24 | 拜尔梅里科有限公司 | 抑郁症敏感测试的组合物、设备以及方法 |
| CN110716055A (zh) * | 2019-09-11 | 2020-01-21 | 天津医科大学 | 过敏原特异性免疫球蛋白e致病活性检测试剂盒 |
| US11143650B1 (en) * | 2020-04-15 | 2021-10-12 | ProteinSimple | Method for measurement of total protein content and detection of protein via immunoassay in a microfluidic device |
| EP4212874A4 (en) * | 2020-09-07 | 2024-03-06 | Mitsubishi Gas Chemical Company, Inc. | METHOD FOR DETERMINING ALLERGIC DISEASES AND DETERMINATION SYSTEM |
| JP7555788B2 (ja) * | 2020-10-30 | 2024-09-25 | アサヒグループホールディングス株式会社 | タンパク質の起源種判別方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5736362A (en) * | 1990-10-26 | 1998-04-07 | The University Of Melbourne | Ryegrass pollen allergen |
| US5567594A (en) | 1991-04-26 | 1996-10-22 | Enteron, L.P. | Methods and compositions for the detection and treatment of diseases associated with antigens of microorganisms |
| US5480972A (en) * | 1992-10-30 | 1996-01-02 | The University Of Melbourne | Allergenic proteins from Johnson grass pollen |
| US5558869A (en) * | 1992-12-30 | 1996-09-24 | University Of Arkansas | Major peanut allergen ara h II |
| ATE318902T1 (de) * | 1992-12-31 | 2006-03-15 | Immulogic Pharma Corp | Allergene proteine und peptide von hundhautanhangsgebilden und ihre verwendung |
-
1999
- 1999-01-28 EP EP99903464A patent/EP1051626B1/en not_active Expired - Lifetime
- 1999-01-28 JP JP2000529614A patent/JP4292262B2/ja not_active Expired - Fee Related
- 1999-01-28 ES ES99903464T patent/ES2229673T3/es not_active Expired - Lifetime
- 1999-01-28 AT AT99903464T patent/ATE426170T1/de not_active IP Right Cessation
- 1999-01-28 AT AT08005972T patent/ATE550665T1/de active
- 1999-01-28 AU AU23478/99A patent/AU741635B2/en not_active Ceased
- 1999-01-28 EP EP08005972A patent/EP1939628B1/en not_active Expired - Lifetime
- 1999-01-28 US US09/238,448 patent/US6238925B1/en not_active Expired - Lifetime
- 1999-01-28 CA CA002319317A patent/CA2319317C/en not_active Expired - Fee Related
- 1999-01-28 WO PCT/US1999/001832 patent/WO1999039211A1/en not_active Ceased
- 1999-01-28 DE DE69919327T patent/DE69919327D1/de not_active Expired - Lifetime
- 1999-01-28 ES ES08005972T patent/ES2383002T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| HK1120865A1 (en) | 2009-04-09 |
| JP4292262B2 (ja) | 2009-07-08 |
| DE69919327T2 (de) | 2005-03-10 |
| ATE426170T1 (de) | 2009-04-15 |
| EP1939628A1 (en) | 2008-07-02 |
| AU741635B2 (en) | 2001-12-06 |
| DE69919327D1 (de) | 2009-11-26 |
| US6238925B1 (en) | 2001-05-29 |
| WO1999039211A1 (en) | 1999-08-05 |
| CA2319317A1 (en) | 1999-08-05 |
| HK1032262A1 (en) | 2001-07-13 |
| JP2002502039A (ja) | 2002-01-22 |
| EP1051626A1 (en) | 2000-11-15 |
| ES2229673T3 (es) | 2009-08-04 |
| AU2347899A (en) | 1999-08-16 |
| ES2383002T3 (es) | 2012-06-15 |
| EP1939628B1 (en) | 2012-03-21 |
| EP1051626B1 (en) | 2009-03-18 |
| ATE550665T1 (de) | 2012-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2319317C (en) | Prognostic allergy or inflammation test | |
| Järvinen et al. | Specificity of IgE antibodies to sequential epitopes of hen's egg ovomucoid as a marker for persistence of egg allergy | |
| EP2478373B1 (en) | Methods for characterizing antibody binding affinity and epitope diversity in food allergy | |
| US20150168389A1 (en) | Methods Of Determining Allergen Response Using Microarray Immunoassay Techniques | |
| EP2136211B1 (en) | Determination method for allergic disease | |
| Carroccio et al. | Diagnostic accuracy of fecal elastase 1 assay in patients with pancreatic maldigestion or intestinal malabsorption | |
| CA2992044A1 (en) | An improved assay for the diagnosis of peanut allergy | |
| US7258994B2 (en) | Saliva immunoassay for detection of antibodies for cardiovascular disease | |
| JP5633721B2 (ja) | 乳幼児のアレルギー発症を予測するためのデータを提供する方法 | |
| CN113287013A (zh) | 溃疡性大肠炎以及原发性硬化性胆管炎的检查方法 | |
| Garrote et al. | A novel visual immunoassay for coeliac disease screening | |
| Germano et al. | Specific humoral response to cows’ milk proteins and ovalbumin in children with atopic dermatitis | |
| JP7385302B2 (ja) | アナフィラキシーの発症を予測するためのデータを収集する方法 | |
| HK1032262B (en) | Prognostic allergy or inflammation test | |
| HK1120865B (en) | Prognostic allergy test | |
| JP2022096812A (ja) | 抗原ポリペプチド | |
| JP7585025B2 (ja) | 歯周病原菌に対する抗体価を測定する方法 | |
| Hamilton | In vitro diagnostic methods in the evaluation of food hypersensitivity | |
| Laan et al. | MARKERS FOR EARLY SENSITISATION AND INFLAMMATION | |
| Raesan et al. | Preparation of allergenfrom chicken egg and evaluated of their abilityto anaphylaxis's in patients suffering from allergy. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20150128 |